American Century Companies Inc. Purchases 602,091 Shares of SIGA Technologies, Inc. (NASDAQ:SIGA)

American Century Companies Inc. grew its position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) by 251.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 841,759 shares of the company’s stock after acquiring an additional 602,091 shares during the period. American Century Companies Inc. owned about 1.18% of SIGA Technologies worth $6,389,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Steward Partners Investment Solutions LLC purchased a new position in SIGA Technologies during the 4th quarter valued at about $58,000. Bayesian Capital Management LP purchased a new position in shares of SIGA Technologies during the first quarter valued at approximately $97,000. Lazard Asset Management LLC purchased a new stake in SIGA Technologies in the first quarter worth $105,000. EntryPoint Capital LLC purchased a new stake in SIGA Technologies in the first quarter worth $111,000. Finally, Onyx Bridge Wealth Group LLC increased its position in SIGA Technologies by 15.0% during the 1st quarter. Onyx Bridge Wealth Group LLC now owns 13,000 shares of the company’s stock valued at $114,000 after purchasing an additional 1,700 shares during the period. 55.40% of the stock is currently owned by hedge funds and other institutional investors.

SIGA Technologies Trading Down 5.0 %

NASDAQ:SIGA opened at $8.01 on Wednesday. The company has a 50-day moving average price of $9.01 and a 200-day moving average price of $8.36. The stock has a market cap of $569.70 million, a price-to-earnings ratio of 7.28 and a beta of 0.91. SIGA Technologies, Inc. has a 12 month low of $4.26 and a 12 month high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.03 EPS for the quarter. SIGA Technologies had a net margin of 48.55% and a return on equity of 51.40%. The business had revenue of $21.81 million during the quarter. During the same quarter last year, the business earned ($0.04) earnings per share. Equities analysts forecast that SIGA Technologies, Inc. will post 1.01 EPS for the current fiscal year.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.